473 related articles for article (PubMed ID: 17896088)
21. Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme.
Koot RW; Maarouf M; Hulshof MC; Voges J; Treuer H; Koedooder C; Sturm V; Bosch DA
Cancer; 2000 Jun; 88(12):2796-802. PubMed ID: 10870063
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
[TBL] [Abstract][Full Text] [Related]
23. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
25. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
26. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
27. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
28. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
29. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
[TBL] [Abstract][Full Text] [Related]
30. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
31. Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.
Miwa K; Matsuo M; Ogawa S; Shinoda J; Yokoyama K; Yamada J; Yano H; Iwama T
Radiat Oncol; 2014 Aug; 9():181. PubMed ID: 25123357
[TBL] [Abstract][Full Text] [Related]
32. Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.
Yoshida K; Yamazaki H; Kotsuma T; Takenaka T; Masui K; Yoshioka Y; Uesugi Y; Shimbo T; Yoshikawa N; Yoshioka H; Narumi Y; Tatsumi K; Tanaka E
Brachytherapy; 2015; 14(4):440-8. PubMed ID: 25858904
[TBL] [Abstract][Full Text] [Related]
33. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
[TBL] [Abstract][Full Text] [Related]
34. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
Lee LJ; Damato AL; Viswanathan AN
Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
[TBL] [Abstract][Full Text] [Related]
36. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
37. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
39. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
[TBL] [Abstract][Full Text] [Related]
40. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
